To Assess the Efficacy and Safety of Vildagliptin as Add-on Therapy to Sulfonylurea in Patients With Type 2 Diabetes Inadequately Controlled With Sulfonylurea Monotherapy
Clinical trial NCT00325117 · COMPLETED
Trial details
- NCT number
- NCT00325117
- Sponsor
- Novartis
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-04-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.